Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 17 member 4 (SLC17A4) is a membrane transporter protein belonging to the solute carrier (SLC) superfamily, specifically the SLC17 family, which includes vesicular glutamate and organic anion transporters[1]. SLC17A4 is predicted to be involved in the sodium/phosphate co-transport and/or transport of other charged organic molecules across cellular membranes, though its substrate specificity and physiological role are less well-defined than other SLC17 family members[1]. Like other SLC transporters, SLC17A4 is an integral membrane protein characterized by multiple transmembrane domains[1]. While the broader SLC17 family participates in critical physiological functions, including neurotransmitter transport and metabolic substrate flux, detailed biological or therapeutic roles for SLC17A4 itself remain incompletely characterized. As with other SLC proteins, research is ongoing to clarify its function, disease relevance, and therapeutic potential[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 17 member 4 (SLC17A4).